SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATOR
A compound is provided having following structure Compound (1): or a pharmaceutically acceptable salt, homolog, hydrate or solvate thereof. Also provided is a pharmaceutical composition comprising Compound (1) or a pharmaceutically acceptable salt, homolog, hydrate or solvate thereof, in combination with a pharmaceutically acceptable carrier or diluent.
1 . An isolated or purified form of a compound having the following structure (Compound 1):
or a pharmaceutically acceptable salt, homolog, hydrate or solvate thereof.
2 . The isolated or purified form of the compound of claim 1 , wherein Compound 1 is present at a purity in excess of 90% (w/w).
3 . The isolated or purified form of the compound of claim 1 , wherein Compound 1 is present at a purity in excess of 95% (w/w).
4 . The isolated or purified form of the compound of claim 1 , wherein Compound 1 is present at a purity in excess of 98% (w/w).
5 . The isolated or purified form of the compound of claim 1 , wherein Compound 1 is present at a purity in excess of 98% (w/w).
6 . The isolated or purified form of the compound of claim 1 , wherein Compound 1 is present at a purity in excess of 99% (w/w).
7 . A pharmaceutical composition comprising a compound having the following structure (Compound 1):
or a pharmaceutically acceptable salt, homolog, hydrate or solvate thereof, in combination with a pharmaceutically acceptable carrier or diluent.
8 . The pharmaceutical composition of claim 7 , wherein the composition is in a form suitable for oral administration.
9 . The pharmaceutical composition of claim 7 , wherein the composition is in a form suitable for intravenous administration.